a type 2 therapeutic trial consisting of the administration of monthly cycles of chemohormonotherapy , each cycle combining weekly sequences of mephalan , prednisone , cyclophosphamide , and prednisone , has been achieved in 20 stage ii or iii myeloma patients .
C0010583
cyclophosphamide
C0026764
myeloma